| Term 
 | Definition 
 
        | Relieves urinary retention and postoperative abd distention. Cholinergic Drugs (parasympathomimetics) *Direct Acting* |  | 
        |  | 
        
        | Term 
 
        | Direct-acting Cholinergic (parasympathomimetics) |  | Definition 
 
        | Stimulate the parasympathic nervous system directly in the same manner as acetylcholine. Decrease heart rate Increased tone and contractility in the gastrointestinal smooth muscles. Increased salivary gland and GI secretions Increased tone and contractility of smooth muscle in the urinary bladder Increased respiratory secretions Increased tone/contractility of bronchial smooth muscle |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Myasthenia gravis and antidote for skeletal muscle relaxants used in surgery. *Indirect acting* Cholinergic (parasympathomimetics) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alzheimers disease *indirect acting* Cholinergic (parasympathomimetics) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Abdominal discomfort,diarrhea,nausea,vomiting Bronchospasms and Bradycardia  (if these occur,withhold medicine and consult physician) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antidote for cholinergic drugs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Increases heart rate in bradycardia and heart block. Used before surgery to reduce respiratory tract secretion. Anticholinergic Drugs (Blocking Agents) (Parasympatholytic) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Decreases secretions Anticholinergic Blocking agent Parasympatholytic |  | 
        |  | 
        
        | Term 
 
        | Urispas,Ditropan, & Detrol |  | Definition 
 
        | antipasmotic effects to relieve urinary incontinence and frequency. Anticholinergic Blocking agent Parasympatholytic |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Parkinson's Disease Anticholinergic Blocking agent Parasympatholytic   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | maintain mydiasis during eye exam Anticholinergic  Blocking agent Parasympatholytic  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | asthma and chronic bronchitis Anticholinergic Blocking agent Parasympatholytic |  | 
        |  | 
        
        | Term 
 
        | Anticholinergic Drugs Blocking Agents Parasympatholytic   |  | Definition 
 
        | blocks the action of acetycholine in the parasympathetic nervous sytem. |  | 
        |  | 
        
        | Term 
 
        | Anticholinergic  Block Agents  Parasympatholytic |  | Definition 
 
        | occupy receptor sites at parasympathetic nerve endings which prevents the action of acetycholine. Decreases cardiovascular responses to vagal stimulation. Bronchodilation/decreased respiratory tract secretions. Antispasmotic effects in the GI tract Mydriais (dilation of pupil) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blurred vision,constipation,dry mouth, tachycardia. |  | 
        |  | 
        
        | Term 
 
        | Vanceril  (oral inhalation) Vancenase,Flonase, and Beconase (nasel inhalation)     |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cortone (cortisone) Dacadron (dexamethasone) Hydrocortone or Cortef (Hydrocortisone) Solu-medrol (methylypredisolone succinate) Deltasone (prednisone) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | To correct a deficent state in the body and exert an antiinflammatory, immuno-suppressive,antiallergic, and antistress effects. Allergic to reactions to medications Collagen disorders-systemic lupus erthematosus Dermatologic disorders-contact dermantitis GI problems-Crohn's disease Neurologic disorders-cerebral edema,acute spinal cord injury Organ and tissue transplants-prevent rejection Renal disease-nephrotic syndrome Respiratory disorders-asthma,COPD,rhinitis Rheumatic disorders-arthritis Endocrine disorders |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | " cushingoid"appearance-moon face,bufflo hump,obese trunk. Hyperglycemia CNS effects-euphoria,depression Musculoskeletal effects-osteoporosis,pathologic fractures GI effects-bleeding Increased susceptibility to infection and delayed wound healing Menstruak irregularites Cardiovascular effects-fluid retention,edema.hypertension. |  | 
        |  | 
        
        | Term 
 
        | Synthroid (levothyroxine) |  | Definition 
 
        | Throid Drug treats hypothyroidism |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | replace the deficient thyroid hormones T3 and T4 in hypothyroidism or in clients who have had their thyroid gland removed. Control rate cellular metabolism,stimulate protein synthesis. Promote cell growth. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | tachycardia weight loss intolerance to heat nervousness insomnia diarrhea angina MI CHF |  | 
        |  | 
        
        | Term 
 
        | PTU(propylthiourcil) Tapazole (no peripheral activity) Lugol's solution (strong iodine solution) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | treat hyperthyroidism and prepare client for a thyroidectomy. Inhibit the production of thyroid hormones and the peripheral conversion of T4 to T3. |  | 
        |  | 
        
        | Term 
 
        | Anti-thyroid-Lugol's Solution |  | Definition 
 
        | can cause iodism-metallic tastemburning in mouth, and gum soreness |  | 
        |  | 
        
        | Term 
 
        | Anti-thyroid-PTU and Tapazole |  | Definition 
 
        | Rash nausea vomiting may see signs of hypothyroidism(bradycardia,constipation,weight gain,excessive sleeping, and slow speech.) |  | 
        |  | 
        
        | Term 
 
        | Humalog(insulin lispro) NovoLog ( insulin aspart) |  | Definition 
 
        | Rapid-Acting Analogs Antidiabetic (Insulin) |  | 
        |  | 
        
        | Term 
 
        | Regular IIentin II Humulin R Novolin R |  | Definition 
 
        | short-acting antidiabetic Insulin |  | 
        |  | 
        
        | Term 
 
        | NPH Iletin II Humulin N Novolin N |  | Definition 
 
        | Intermediate-Acting Antidiabetic Drugs Insulin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mixed Antidiabetic Drug Insulin |  | 
        |  | 
        
        | Term 
 
        | Antidiabetic Drugs Insulin |  | Definition 
 
        | lower-blood glucose levels in Type 1 (insulin-dependent) diabetes and Type 2(non-insulin dependent) diabetes. May be needed in clients with Type 2 who experiencing stress from surgery,illness,or infection. |  | 
        |  | 
        
        | Term 
 
        | Antidiabetic Drugs Insulin  |  | Definition 
 
        | increases glucose transport into most body cells. Decreases breakdown of glycogen (glycogenolysis) Decreases formation of new glucose from  amino acids and fatty acids. Increases glycogen synthesis. |  | 
        |  | 
        
        | Term 
 
        | Antidiabetic drugs Insulin |  | Definition 
 
        | Hypoglycemia:,nervousness,cool,clammy skin,irritability,blurred or double vision,convulsions,coma. Lipodystrophy:atrophy or "dimping" at the injection site from too frequent injections into same site. Uncommon with human insulin. |  | 
        |  | 
        
        | Term 
 
        | Sulfonylureas(Glucotrol,DiaBeta) Alpha-Glucosidase  Inhibitors (Glycet) Biguanide (Glucophage)-metformin Glitazones (Avandia) Meglitinides  (Prandin) |  | Definition 
 
        | Oral Hypoglycemic (Diabetic) Drugs |  | 
        |  | 
        
        | Term 
 
        | Oral Hypoglycemic (Diabetic) Drugs |  | Definition 
 
        | Lower blood sugar levels in Type 2 diabetes only. Stimulates beta cells to produce and release more insulin. Increase tissue responsiveness to insulin and increase peripheral use of glucose. Decrease production of glucose in the liver. |  | 
        |  | 
        
        | Term 
 
        | Oral Hypoglycemic (Diabetic) Drugs
 |  | Definition 
 
        | Hypoglycemia,weight gain (except for metformin) |  | 
        |  | 
        
        | Term 
 
        | Premarin Depo-Estradiol Estrogel(topical gel)  Estroderm(patch) Oral Contraceptives(along with progestin) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Promotes growth in tissue related to reproduction and sexual characteristics in women. Replacement therapy in deficiency states Component in birthcontrol pills During menopause to control vaginitis and hot flashes Post menopausal prevention/treatment of osteoporosis & cardiovascular disease. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nausea vomiting H/A Thrombophlebitis Weight gain Hypertension |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | They enter target cells and combine with receptor proteins to form an estrogen-receptor complex that interacts with DNA. |  | 
        |  | 
        
        | Term 
 
        | Oral Potassium Chloride sustained release tablets K0Dur,Slow-K |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Oral potassium chloride side effects |  | Definition 
 
        | GI upset nausea vomiting diarrhea |  | 
        |  | 
        
        | Term 
 
        | Intravenous Potassium Chloride |  | Definition 
 
        | Must be diluted in IV fluids and infused slowly. It should never be given IV push because it will result in cardiac arrest |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Serum potassium level is below 3.5 mEq/L as a result of taking certain diuretics, insuffcient potassium potassium intake, vomiting and diarrhea. |  | 
        |  | 
        
        | Term 
 
        | Vitamin-Vitamin K (mephyton) |  | Definition 
 
        | required for synthesis of prothrombin and three other clotting factors which needed for coagulation of blood. Normal newborn is born vitamin K deficient. They are given an injection immediately after delivery to reduce risk of hemorrage. |  | 
        |  |